vimarsana.com

Latest Breaking News On - News ratings for regeneron pharmaceuticals daily - Page 1 : vimarsana.com

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) CEO Sells $9,203,857 52 in Stock

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of Regeneron Pharmaceuticals stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $1,015.43, for a total transaction of $9,203,857.52. Following the transaction, the chief executive officer now owns 55,134 shares […]

Insider Selling: Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) CEO Sells 9,064 Shares of Stock

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of Regeneron Pharmaceuticals stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $1,015.43, for a total transaction of $9,203,857.52. Following the sale, the chief executive officer now directly owns 55,134 shares of […]

Forefront Analytics LLC Buys 26 Shares of Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Forefront Analytics LLC boosted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 8.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 319 shares of the biopharmaceutical company’s stock after buying an additional 26 shares during the period. Forefront Analytics LLC’s […]

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Shares Bought by Avidity Partners Management LP

Avidity Partners Management LP grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 17.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 68,000 shares of the biopharmaceutical company’s stock after purchasing an additional 10,000 shares during the period. Regeneron Pharmaceuticals […]

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Shares Bought by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 259.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 18,553 shares of the biopharmaceutical company’s stock after acquiring an additional 13,392 shares during the period. Tower Research Capital LLC TRC’s holdings in Regeneron Pharmaceuticals […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.